India's Venus Remedies up on nod to market drugs in Saudi Arabia, Phillippines

Venus Remedies

01/12/2023 08:42

** Shares of Venus Remedies  VENR.NS  up as much as 4.9% at
405 rupees
    ** Pharmaceutical formulations maker receives marketing
authorisation for osteoporosis drug Zoledronic Acid and
chemotherapy medicine Paclitaxel in Phillipines 
    ** VENR also gets marketing authorisation for cancer drug 
Bleomycin in Saudi Arabia
    ** Over 164,000 shares traded, 0.9x the 30-day moving
average
    ** Stock more than doubled so far this year

 (Reporting by Kashish Tandon in Bengaluru)
 ((kashish.tandon@thomsonreuters.com))